Introduction
Cette page fournit une analyse complète de l'historique des opérations d'initiés connues de David P Schenkein. Les initiés sont des dirigeants, des administrateurs ou des investisseurs importants dans une entreprise. Il est illégal pour les initiés d'effectuer des opérations d'initiés dans leur entreprise sur la base d'informations spécifiques et non publiques. Cela ne signifie pas qu'il est illégal pour eux d'effectuer toute transaction dans leur propre entreprise. Toutefois, ils doivent déclarer toutes les opérations à la SEC au moyen d'un formulaire 4. Malgré ces restrictions, les recherches universitaires indiquent que les initiés, en général, ont tendance à surperformer le marché dans leurs propres entreprises.
Rentabilité moyenne des opérations
La rentabilité moyenne des opérations est le rendement moyen de tous les achats effectués par l'initié sur le marché public au cours des trois dernières années. Pour ce faire, nous examinons tous les achats non planifiés effectués par l'initié sur le marché public, à l'exclusion de toutes les opérations d'initiés effectuées dans le cadre d'un plan de négociation 10b5-1. Nous calculons ensuite la performance moyenne de ces transactions sur 3, 6 et 12 mois, en faisant la moyenne de chacune de ces durées pour générer un indicateur de performance final pour chaque opération. Enfin, nous faisons la moyenne de tous les indicateurs de performance pour calculer un indicateur de performance pour l'initié. Cette liste ne comprend que les initiés ayant effectué au moins trois opérations d'initiés au cours des deux dernières années.
Si la rentabilité des opérations de cet initié est "N/A", cela signifie qu'il n'a pas effectué d'opérations d'achat sur le marché public au cours des trois dernières années, ou que les opérations qu'il a effectuées sont trop récentes pour permettre le calcul d'un indicateur de performance fiable.
Fréquence de mise à jour : Quotidienne
Entreprises ayant déclaré des positions d'initiés
Les dépôts de la SEC indiquent que David P Schenkein a déclaré des participations ou des opérations dans les entreprises suivantes :
Titre | Fonction | Dernières positions déclarées |
---|---|---|
US:DNLI / Denali Therapeutics Inc. | Director | 15 257 |
US:REGN / Regeneron Pharmaceuticals, Inc. | Director | 448 |
US:AGIO / Agios Pharmaceuticals, Inc. | Director | 126 242 |
US:BLUE / bluebird bio, Inc. | Director | 3 000 |
US:FMI / Foundation Medicine, Inc. | Director | 23 326 |
Comment interpréter les graphiques
Les graphiques suivants montrent la performance des titres après chaque opération non planifiée effectuée par David P Schenkein sur le marché public. Les opérations non planifiées sont des opérations qui n'ont pas été effectuées dans le cadre d'un plan de négociation 10b5-1. La performance des actions est représentée sous la forme d'une variation cumulée en pourcentage du cours de l'action. Par exemple, si une opération d'initié a été effectuée le 1er janvier 2019, le graphique montrera la variation quotidienne en pourcentage du titre jusqu'à aujourd'hui. Si le prix de l'action passait de 10 à 15 dollars pendant cette période, la variation cumulée en pourcentage du prix de l'action serait de 50 %. Une variation du cours de 10 à 20 dollars serait de 100 %, et une variation du cours de 10 à 5 dollars serait de -50 %.
Enfin, nous essayons de déterminer dans quelle mesure les opérations d'un initié sont en corrélation avec les rendements excédentaires (positifs ou négatifs) du cours de l'action, afin de déterminer si l'initié synchronise ses opérations pour tirer profit d'informations d'initié. Imaginons qu'un initié agisse de la sorte. Dans ce cas, nous nous attendrions soit (a) à des rendements positifs après les achats, soit (b) à des rendements négatifs après les ventes. Dans le cas (a), le graphique des ACHAT montrerait une série de courbes ascendantes, indiquant des rendements positifs après chaque transaction d'achat. Dans le cas (b), le graphique VENTE montre une série de courbes inclinées vers le bas, indiquant des rendements négatifs après chaque transaction de vente.
Toutefois, cela ne suffit pas pour tirer des conclusions. Si, par exemple, le cours de l'action de l'entreprise a connu une hausse non cyclique pendant de nombreuses années, nous nous attendrions à ce que tous les graphiques postérieurs à l'achat soient en pente ascendante. De même, des baisses non cycliques sur de nombreuses années se traduiraient par des graphiques post-achat en pente descendante. Aucun de ces graphiques ne suggère l'existence d'opérations d'initiés.
L'indicateur le plus fort serait une situation dans laquelle le prix de l'action serait extrêmement cyclique et où il y aurait à la fois des signaux positifs dans le graphique ACHAT et des courbes négatives dans le graphique VENTE. Cette situation suggère fortement la présence d'un initié qui planifie les opérations d'initiés de manière à en tirer un avantage financier.
Achats d'initiés AGIO / Agios Pharmaceuticals, Inc. - Analyse des bénéfices à court terme
Dans cette section, nous analysons la rentabilité de chaque achat d'initié non planifié et effectué sur le marché public dans AGIO / Agios Pharmaceuticals, Inc.. Cette analyse permet de comprendre si l'initié génère régulièrement des rendements anormaux et s'il vaut la peine d'être suivi. Cette analyse porte sur l'année qui suit chaque opération, tout en sachant que les résultats sont théoriques.
Le tableau suivant présente les achats les plus récents sur le marché public qui ne faisaient pas partie d'un plan de trading automatique.
Date de l'opération | Libellé | Initié | Actions déclarées |
Prix déclaré |
Actions ajustées |
Prix ajusté |
Coût de base | Jours jusqu'à Max |
Prix à Max |
Bénéfice Max ($) |
Rendement maximal (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2019-11-13 | AGIO | Schenkein David P | 8 064 | 31,0000 | 8 064 | 31,0000 | 249 984 | 250 | 55.9300 | 201 036 | 80,42 |
Prix ajusté est le prix ajusté après fractionnement. Actions ajustées est le nombre d'actions ajustées après fractionnement.
Ventes d'initiés AGIO / Agios Pharmaceuticals, Inc. - Analyse des pertes à court terme
Dans cette section, nous analysons la capacité à éviter les pertes à court terme lors de chaque vente d'initié non planifiée et réalisée sur le marché public dans AGIO / Agios Pharmaceuticals, Inc.. Un modèle régulier d'évitement des pertes peut suggérer que les transactions de vente futures peuvent prédire des baisses de prix. Cette analyse porte sur un an après chaque opération, tout en sachant que les résultats sont théoriques.
Le tableau suivant présente les dernières opérations sur le marché public qui ne faisaient pas partie d'un plan de trading automatique.
Prix ajusté est le prix ajusté après fractionnement. Actions ajustées est le nombre d'actions ajustées après fractionnement.
Historique des opérations d'initiés
Ce tableau présente la liste complète des opérations d'initiés effectuées par David P Schenkein, telles que divulguées à la Securities Exchange Commission (SEC).
Date de dépôt | Date de l'opération | Formulaire | Libellé | Titre | Code | Actions | Actions restantes | Pourcentage de variation |
Prix de l'action |
Valeur de l'opération |
Valeur restante |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 6 037 | 15 257 | 65,48 | ||||
2025-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 166 | 448 | 58,87 | ||||
2024-11-13 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | -32 312 | 9 220 | -77,80 | 32,87 | -1 062 095 | 303 061 |
2024-11-13 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | -27 129 | 41 532 | -39,51 | 32,09 | -870 570 | 1 332 762 |
2024-11-13 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
M - Exercise | 47 165 | 68 661 | 219,41 | 18,00 | 848 970 | 1 235 898 | |
2024-06-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 3 388 | 126 242 | 2,76 | ||||
2024-06-04 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 5 967 | 21 496 | 38,42 | ||||
2024-02-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | -57 471 | 122 854 | -31,87 | 34,89 | -2 005 163 | 4 286 376 | |
2024-02-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 57 471 | 180 325 | 46,78 | 31,64 | 1 818 382 | 5 705 483 | |
2024-02-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | -11 858 | 122 854 | -8,80 | 33,60 | -398 429 | 4 127 894 | |
2024-02-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 11 858 | 134 712 | 9,65 | 31,64 | 375 187 | 4 262 288 | |
2024-02-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | -20 411 | 122 854 | -14,25 | 33,19 | -677 441 | 4 077 524 | |
2024-02-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 20 411 | 143 265 | 16,61 | 31,64 | 645 804 | 4 532 905 | |
2024-02-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | -47 731 | 122 854 | -27,98 | 33,05 | -1 577 510 | 4 060 325 | |
2024-02-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 47 731 | 170 585 | 38,85 | 31,64 | 1 510 209 | 5 397 309 | |
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 42 | 282 | 17,50 | ||||
2023-09-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 240 | 240 | |||||
2023-06-23 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 4 975 | 122 854 | 4,22 | ||||
2023-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 4 216 | 15 529 | 37,27 | ||||
2023-04-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -16 363 | 117 879 | -12,19 | 22,85 | -373 895 | 2 693 535 |
2023-04-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 16 363 | 134 242 | 13,88 | 9,05 | 148 085 | 1 214 890 |
2023-03-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -20 000 | 117 879 | -14,51 | 22,15 | -443 000 | 2 611 020 |
2023-03-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2023-03-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -1 667 | 117 879 | -1,39 | 22,72 | -37 874 | 2 678 211 |
2023-03-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -18 333 | 119 546 | -13,30 | 22,47 | -411 943 | 2 686 199 |
2023-03-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2023-03-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -20 000 | 117 879 | -14,51 | 25,37 | -507 400 | 2 990 590 |
2023-03-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2023-02-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -20 000 | 117 879 | -14,51 | 28,62 | -572 400 | 3 373 697 |
2023-02-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2023-02-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -3 300 | 117 879 | -2,72 | 29,88 | -98 604 | 3 522 225 |
2023-02-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -16 700 | 121 179 | -12,11 | 29,22 | -487 974 | 3 540 850 |
2023-02-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2023-01-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -1 034 | 117 879 | -0,87 | 29,49 | -30 493 | 3 476 252 |
2023-01-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -18 966 | 118 913 | -13,76 | 28,82 | -546 600 | 3 427 073 |
2023-01-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2022-06-06 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 5 986 | 11 313 | 112,37 | ||||
2022-05-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock unit |
M - Exercise | -1 585 | 0 | -100,00 | ||||
2022-05-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 1 585 | 117 879 | 1,36 | ||||
2022-02-23 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | -2 775 | 0 | -100,00 | ||||
2022-02-23 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
F - Taxes | -758 | 116 294 | -0,65 | 29,08 | -22 043 | 3 381 830 | |
2022-02-23 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 2 775 | 117 052 | 2,43 | ||||
2021-06-04 |
|
4 | DNLI |
Denali Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 6 222 | 6 222 | |||||
2021-06-04 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 2 074 | 5 327 | 63,76 | ||||
2021-06-03 |
|
4 | DNLI |
Denali Therapeutics Inc.
Restricted Stock Units |
M - Exercise | -3 253 | 0 | -100,00 | ||||
2021-06-03 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
M - Exercise | 3 253 | 3 253 | |||||
2021-06-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | -1 686 | 0 | -100,00 | ||||
2021-06-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 1 686 | 114 277 | 1,50 | ||||
2021-05-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Stock options (right to buy) |
A - Award | 8 888 | 8 888 | |||||
2021-05-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock unit |
A - Award | 1 585 | 1 585 | |||||
2021-02-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | -2 774 | 2 775 | -49,99 | ||||
2021-02-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
F - Taxes | -821 | 112 591 | -0,72 | ||||
2021-02-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 2 774 | 113 412 | 2,51 | ||||
2021-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | -8 125 | 0 | -100,00 | ||||
2021-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
F - Taxes | -2 540 | 110 638 | -2,24 | ||||
2021-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 8 125 | 113 178 | 7,73 | ||||
2020-12-23 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | -5 000 | 26 232 | -16,01 | 90,01 | -450 027 | 2 361 022 |
2020-12-23 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | -25 000 | 0 | -100,00 | 90,06 | -2 251 555 | |
2020-11-13 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | -30 000 | 25 000 | -54,55 | 70,05 | -2 101 590 | 1 751 325 |
2020-11-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | -10 000 | 55 000 | -15,38 | 60,03 | -600 310 | 3 301 705 |
2020-11-06 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | -10 000 | 65 000 | -13,33 | 50,18 | -501 830 | 3 261 895 |
2020-06-22 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 3 000 | 3 000 | |||||
2020-06-22 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 500 | 6 832 | 28,13 | ||||
2020-06-22 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 156 | 5 332 | 3,01 | ||||
2020-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Restricted Stock Units |
A - Award | 3 253 | 3 253 | |||||
2020-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 15 183 | 15 183 | |||||
2020-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
A - Award | 1 686 | 1 686 | |||||
2020-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Stock options (right to buy) |
A - Award | 8 096 | 8 096 | |||||
2020-02-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
F - Taxes | -880 | 105 053 | -0,83 | 48,66 | -42 821 | 5 111 879 | |
2020-02-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | -2 775 | 5 549 | -33,34 | ||||
2020-02-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 2 775 | 105 933 | 2,69 | ||||
2020-02-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
F - Taxes | -2 534 | 103 158 | -2,40 | 52,01 | -131 793 | 5 365 248 | |
2020-02-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | -8 125 | 8 125 | -50,00 | ||||
2020-02-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 8 125 | 105 692 | 8,33 | ||||
2019-11-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
P - Purchase | 8 064 | 97 567 | 9,01 | 31,00 | 249 984 | 3 024 577 | |
2019-06-10 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 4 000 | 4 000 | |||||
2019-06-10 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 000 | 5 176 | 23,95 | ||||
2019-06-03 |
|
4 | DNLI |
Denali Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 27 245 | 27 245 | |||||
2019-02-26 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Restricted stock units |
A - Award | 8 324 | 8 324 | |||||
2019-02-26 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 45 719 | 45 719 | |||||
2019-02-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
F - Taxes | -2 471 | 89 503 | -2,69 | 58,03 | -143 392 | 5 193 859 | |
2019-02-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Restricted stock units |
M - Exercise | -8 125 | 16 250 | -33,33 | ||||
2019-02-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 8 125 | 91 974 | 9,69 | ||||
2018-11-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
G - Gift | -1 000 | 270 772 | -0,37 | ||||
2018-09-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -8 730 | 137 471 | -5,97 | ||||
2018-09-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 8 730 | 83 849 | 11,62 | 31,64 | 276 217 | 2 652 982 | |
2018-09-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -2 500 | 146 201 | -1,68 | ||||
2018-09-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -72 619 | 0 | -100,00 | ||||
2018-09-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 2 500 | 75 119 | 3,44 | 31,64 | 79 100 | 2 376 765 | |
2018-09-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 72 619 | 72 619 | 2,34 | 169 928 | 169 928 | ||
2018-06-22 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 4 000 | 4 000 | |||||
2018-06-22 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 000 | 4 176 | 31,49 | ||||
2018-06-15 |
|
4 | DNLI |
Denali Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 27 830 | 27 830 | |||||
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -108 | 72 619 | -0,15 | |||
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -12 892 | 0 | -100,00 | |||
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -100 | 0 | -100,00 | 96,91 | -9 691 | |
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 190 | 100 | -96,96 | 96,40 | -307 516 | 9 640 |
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -8 200 | 3 290 | -71,37 | 95,11 | -779 902 | 312 912 |
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -1 510 | 11 490 | -11,62 | 94,37 | -142 499 | 1 084 311 |
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 108 | 13 000 | 0,84 | 2,34 | 253 | 30 420 |
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 12 892 | 12 892 | 0,47 | 6 027 | 6 027 | |
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -23 471 | 12 892 | -64,55 | |||
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -16 193 | 0 | -100,00 | |||
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -5 962 | 0 | -100,00 | |||
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -45 626 | 0 | -100,00 | 90,07 | -4 109 534 | |
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 23 471 | 45 626 | 105,94 | 0,47 | 10 973 | 21 330 |
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 16 193 | 22 155 | 271,60 | 0,30 | 4 898 | 6 702 |
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 5 962 | 5 962 | 0,30 | 1 804 | 1 804 | |
2018-05-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -49 374 | 16 193 | -75,30 | |||
2018-05-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -299 | 0 | -100,00 | 92,03 | -27 517 | |
2018-05-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -9 301 | 299 | -96,89 | 91,60 | -851 972 | 27 388 |
2018-05-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -39 774 | 9 600 | -80,56 | 90,11 | -3 584 035 | 865 056 |
2018-05-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 49 374 | 49 374 | 0,30 | 14 936 | 14 936 | |
2018-05-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -13 000 | 65 567 | -16,55 | |||
2018-05-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -100 | 0 | -100,00 | 84,35 | -8 435 | |
2018-05-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 814 | 100 | -96,57 | 83,56 | -235 138 | 8 356 |
2018-05-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -10 086 | 2 914 | -77,58 | 82,88 | -835 928 | 241 512 |
2018-05-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 13 000 | 13 000 | 0,30 | 3 932 | 3 932 | |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -13 000 | 78 567 | -14,20 | |||
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 113 | 0 | -100,00 | 79,49 | -167 962 | |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 390 | 2 113 | -61,60 | 78,59 | -266 420 | 166 061 |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 340 | 5 503 | -37,77 | 77,76 | -259 718 | 427 913 |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 600 | 8 843 | -22,72 | 76,40 | -198 640 | 675 605 |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -1 557 | 11 443 | -11,98 | 75,54 | -117 616 | 864 404 |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 13 000 | 13 000 | 0,30 | 3 932 | 3 932 | |
2018-03-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -13 000 | 91 567 | -12,43 | |||
2018-03-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -10 085 | 0 | -100,00 | 81,30 | -819 910 | |
2018-03-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 915 | 10 085 | -22,42 | 80,38 | -234 308 | 810 632 |
2018-03-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 13 000 | 13 000 | 0,30 | 3 932 | 3 932 | |
2018-02-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Restricted stock units |
A - Award | 24 375 | 24 375 | |||||
2018-02-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 97 500 | 97 500 | |||||
2018-02-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -13 000 | 104 567 | -11,06 | |||
2018-02-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -4 460 | 0 | -100,00 | 79,23 | -353 366 | |
2018-02-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -8 540 | 4 460 | -65,69 | 78,50 | -670 390 | 350 110 |
2018-02-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 13 000 | 13 000 | 0,30 | 3 932 | 3 932 | |
2018-01-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -23 572 | 117 567 | -16,70 | |||
2018-01-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 966 | 0 | -100,00 | 82,22 | -243 865 | |
2018-01-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -11 369 | 2 966 | -79,31 | 81,40 | -925 437 | 241 432 |
2018-01-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -9 237 | 14 335 | -39,19 | 80,35 | -742 193 | 1 151 817 |
2018-01-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 23 572 | 23 572 | 0,30 | 7 131 | 7 131 | |
2018-01-26 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -20 | 141 139 | -0,01 | |||
2018-01-26 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -20 | 0 | -100,00 | 80,01 | -1 600 | |
2018-01-26 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 20 | 20 | 0,30 | 6 | 6 | |
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -13 533 | 141 159 | -8,75 | |||
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -13 533 | 0 | -100,00 | 80,01 | -1 082 775 | |
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 13 533 | 13 533 | 0,30 | 4 094 | 4 094 | |
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -32 875 | 5 962 | -84,65 | |||
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -32 875 | 0 | -100,00 | 80,01 | -2 630 329 | |
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 32 875 | 32 875 | 0,30 | 9 945 | 9 945 | |
2018-01-25 |
|
4/A | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -6 000 | 38 837 | -13,38 | |||
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -53 000 | 154 692 | -25,52 | |||
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 597 | 0 | -100,00 | 74,80 | -493 456 | |
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -10 914 | 6 597 | -62,33 | 74,11 | -808 837 | 488 904 |
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -22 304 | 17 511 | -56,02 | 73,02 | -1 628 638 | 1 278 653 |
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -13 185 | 39 815 | -24,88 | 71,77 | -946 287 | 2 857 523 |
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 53 000 | 53 000 | 0,30 | 16 032 | 16 032 | |
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Series A-1 Preferred Stock |
C - Conversion | -19 774 | 0 | -100,00 | ||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Series A-1 Preferred Stock |
C - Conversion | -19 774 | 0 | -100,00 | ||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Series A-1 Preferred Stock |
C - Conversion | -105 225 | 0 | -100,00 | ||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Series A-1 Preferred Stock |
C - Conversion | -105 225 | 0 | -100,00 | ||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
C - Conversion | 19 774 | 19 774 | |||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
C - Conversion | 19 774 | 19 774 | |||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
C - Conversion | 105 225 | 105 225 | |||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
C - Conversion | 105 225 | 105 225 | |||||
2017-12-08 |
|
4 | DNLI |
Denali Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 47 165 | 47 165 | |||||
2017-12-07 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
150 000 | ||||||||
2017-12-07 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
150 000 | ||||||||
2017-12-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -6 000 | 20 656 | -22,51 | |||
2017-12-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -400 | 0 | -100,00 | 62,08 | -24 832 | |
2017-12-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -5 600 | 400 | -93,33 | 61,51 | -344 456 | 24 604 |
2017-12-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 000 | 6 000 | 0,30 | 1 815 | 1 815 | |
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -6 000 | 26 656 | -18,37 | |||
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -4 260 | 0 | -100,00 | 63,32 | -269 743 | |
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -942 | 4 260 | -18,11 | 64,64 | -60 891 | 275 366 |
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -598 | 5 202 | -10,31 | 65,42 | -39 121 | 340 315 |
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -200 | 5 800 | -3,33 | 66,75 | -13 350 | 387 150 |
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 000 | 6 000 | 0,30 | 1 815 | 1 815 | |
2017-10-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -80 000 | 32 656 | -71,01 | |||
2017-10-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -80 000 | 0 | -100,00 | 70,14 | -5 611 200 | |
2017-10-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 80 000 | 80 000 | 0,30 | 24 200 | 24 200 | |
2017-10-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -6 000 | 112 656 | -5,06 | |||
2017-10-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 000 | 0 | -100,00 | 66,76 | -400 560 | |
2017-10-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 000 | 6 000 | 0,30 | 1 815 | 1 815 | |
2017-09-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -35 000 | 118 656 | -22,78 | |||
2017-09-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -35 000 | 0 | -100,00 | 67,12 | -2 349 200 | |
2017-09-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 35 000 | 35 000 | 0,30 | 10 588 | 10 588 | |
2017-09-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
G - Gift | -500 | 271 772 | -0,18 | ||||
2017-09-05 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | -2 000 | 19 361 | -9,36 | ||||
2017-09-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | -2 000 | 3 176 | -38,64 | 115,07 | -230 145 | 365 470 | |
2017-09-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 2 000 | 5 176 | 62,97 | 8,16 | 16 312 | 42 214 | |
2017-09-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -6 000 | 153 656 | -3,76 | |||
2017-09-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 000 | 0 | -100,00 | 62,20 | -373 200 | |
2017-09-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 000 | 6 000 | 0,30 | 1 815 | 1 815 | |
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -24 000 | 159 656 | -13,07 | |||
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -24 000 | 0 | -100,00 | 60,55 | -1 453 200 | |
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 24 000 | 24 000 | 0,30 | 7 260 | 7 260 | |
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -3 000 | 183 656 | -1,61 | |||
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 000 | 0 | -100,00 | 55,12 | -165 360 | |
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 000 | 3 000 | 0,30 | 908 | 908 | |
2017-07-06 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -3 000 | 186 656 | -1,58 | |||
2017-07-06 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 000 | 0 | -100,00 | 51,18 | -153 540 | |
2017-07-06 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 000 | 3 000 | 0,30 | 908 | 908 | |
2017-06-12 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 4 000 | 4 000 | |||||
2017-06-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 000 | 3 176 | 45,96 | ||||
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -1 900 | 189 656 | -0,99 | |||
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -1 900 | 0 | -100,00 | 50,02 | -95 038 | |
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 1 900 | 1 900 | 0,30 | 575 | 575 | |
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -1 100 | 191 556 | -0,57 | |||
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -1 100 | 0 | -100,00 | 50,02 | -55 022 | |
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 1 100 | 1 100 | 0,30 | 333 | 333 | |
2017-05-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -3 000 | 192 656 | -1,53 | |||
2017-05-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 000 | 0 | -100,00 | 50,06 | -150 180 | |
2017-05-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 000 | 3 000 | 0,30 | 908 | 908 | |
2017-04-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -3 000 | 195 656 | -1,51 | |||
2017-04-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 000 | 0 | -100,00 | 58,62 | -175 860 | |
2017-04-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 000 | 3 000 | 0,30 | 908 | 908 | |
2017-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | -5 000 | 21 361 | -18,97 | ||||
2017-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | -5 000 | 2 176 | -69,68 | 89,53 | -447 632 | 194 810 | |
2017-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 5 000 | 7 176 | 229,78 | 8,16 | 40 779 | 58 526 | |
2017-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -3 000 | 198 656 | -1,49 | |||
2017-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 000 | 0 | -100,00 | 50,47 | -151 410 | |
2017-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 000 | 3 000 | 0,30 | 908 | 908 | |
2017-02-23 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 142 900 | 142 900 | |||||
2017-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -6 000 | 201 656 | -2,89 | |||
2017-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 000 | 0 | -100,00 | 50,01 | -300 060 | |
2017-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 000 | 6 000 | 0,30 | 1 815 | 1 815 | |
2017-01-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 68 182 | 136 363 | 100,00 | ||||
2017-01-23 |
|
4/A | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 000 | 2 176 | 85,03 | ||||
2016-06-20 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
A - Award | 12 075 | 23 326 | 107,32 | 19,93 | 240 655 | 464 887 | |
2016-06-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 4 000 | 4 000 | |||||
2016-06-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 000 | 1 000 | |||||
2016-02-18 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 102 000 | 997 501 | 11,39 | ||||
2016-01-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -20 000 | 895 501 | -2,18 | ||||
2016-01-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 20 000 | 272 272 | 7,93 | 0,30 | 6 050 | 82 362 | |
2016-01-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -10 000 | 915 501 | -1,08 | ||||
2016-01-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 10 000 | 252 272 | 4,13 | 0,30 | 3 025 | 76 312 | |
2016-01-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -10 000 | 925 501 | -1,07 | ||||
2016-01-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 10 000 | 242 272 | 4,31 | 0,30 | 3 025 | 73 287 | |
2015-12-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 68 181 | 935 501 | 7,86 | ||||
2015-10-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -4 000 | 867 320 | -0,46 | |||
2015-10-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -4 000 | 232 272 | -1,69 | 80,26 | -321 040 | 18 642 151 |
2015-10-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 4 000 | 236 272 | 1,72 | 31,64 | 126 560 | 7 475 646 |
2015-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -7 299 | 871 320 | -0,83 | |||
2015-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -701 | 878 619 | -0,08 | |||
2015-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -8 000 | 232 272 | -3,33 | 110,60 | -884 800 | 25 689 283 |
2015-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 7 299 | 240 272 | 3,13 | 31,64 | 230 940 | 7 602 206 |
2015-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 701 | 232 973 | 0,30 | 0,30 | 212 | 70 474 |
2015-06-22 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
A - Award | 5 997 | 11 251 | 114,14 | 32,23 | 193 283 | 362 620 | |
2015-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 7 500 | 7 500 | |||||
2015-06-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 232 272 | -2,72 | 120,67 | -784 355 | 28 028 262 |
2015-06-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 232 272 | -2,72 | 120,67 | -784 355 | 28 028 262 |
2015-05-28 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -8 929 | 85 582 | -9,45 | 120,05 | -1 071 926 | 10 274 119 |
2015-05-28 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
G - Gift | -190 | 94 511 | -0,20 | ||||
2015-05-13 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 093 | 94 701 | -2,16 | 110,03 | -230 293 | 10 419 951 |
2015-05-13 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 107 | 96 794 | -3,11 | 110,01 | -341 801 | 10 648 308 |
2015-05-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -1 300 | 99 901 | -1,28 | 101,32 | -131 716 | 10 121 969 |
2015-05-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 600 | 238 772 | -1,08 | 101,32 | -263 432 | 24 192 379 |
2015-05-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -10 000 | 879 320 | -1,12 | ||||
2015-05-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 10 000 | 241 372 | 4,32 | 0,30 | 3 025 | 73 015 | |
2015-05-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 900 | 231 372 | -1,66 | 93,63 | -365 157 | 21 663 360 |
2015-04-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -1 300 | 101 201 | -1,27 | 100,03 | -130 039 | 10 123 136 |
2015-04-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 600 | 235 272 | -1,09 | 100,03 | -260 078 | 23 534 258 |
2015-04-14 |
|
4/A | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | -25 996 | 5 254 | -83,19 | 50,00 | -1 299 800 | 262 700 | |
2015-04-14 |
|
4/A | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | -25 996 | 5 254 | -83,19 | 50,00 | -1 299 800 | 262 700 | |
2015-04-14 |
|
4/A | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | -25 996 | 5 254 | -83,19 | 50,00 | -1 299 800 | 262 700 | |
2015-04-09 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | -25 218 | 6 032 | -80,70 | 50,00 | -1 260 900 | 301 600 | |
2015-04-09 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | -25 218 | 6 032 | -80,70 | 50,00 | -1 260 900 | 301 600 | |
2015-04-09 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | -25 218 | 6 032 | -80,70 | 50,00 | -1 260 900 | 301 600 | |
2015-04-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 900 | 237 872 | -1,61 | 92,54 | -360 906 | 22 012 675 |
2015-03-09 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 600 | 102 501 | -2,47 | 110,16 | -286 416 | 11 291 510 |
2015-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 136 000 | 889 320 | 18,05 | ||||
2015-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -1 300 | 105 101 | -1,22 | 107,05 | -139 165 | 11 251 062 |
2015-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 241 772 | -2,62 | 107,05 | -695 825 | 25 881 693 |
2015-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -25 000 | 753 320 | -3,21 | ||||
2015-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 25 000 | 248 272 | 11,20 | 0,30 | 7 562 | 75 102 | |
2015-02-13 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -684 | 106 401 | -0,64 | 120,31 | -82 292 | 12 801 104 |
2015-02-13 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -787 | 107 085 | -0,73 | 120,14 | -94 550 | 12 865 192 |
2015-02-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 900 | 107 872 | -3,49 | 114,31 | -445 809 | 12 330 848 |
2015-02-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 223 272 | -2,83 | 114,31 | -743 015 | 25 522 222 |
2015-01-06 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 111 772 | -5,50 | 110,08 | -715 520 | 12 303 862 |
2015-01-06 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 229 772 | -2,75 | 110,08 | -715 520 | 25 293 302 |
2014-12-22 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
P - Purchase | 1 176 | 1 176 | 85,00 | 99 960 | 99 960 | ||
2014-12-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 118 272 | -5,21 | 97,03 | -630 695 | 11 475 932 |
2014-12-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 118 272 | -5,21 | 97,03 | -630 695 | 11 475 932 |
2014-11-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 124 772 | -4,95 | 81,71 | -531 115 | 10 195 120 |
2014-11-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 124 772 | -4,95 | 81,71 | -531 115 | 10 195 120 |
2014-10-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -2 500 | 778 320 | -0,32 | |||
2014-10-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 131 272 | -4,72 | 60,07 | -390 455 | 7 885 509 |
2014-10-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 131 272 | -4,72 | 60,07 | -390 455 | 7 885 509 |
2014-10-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 2 500 | 255 772 | 0,99 | 0,30 | 756 | 77 371 |
2014-09-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -30 000 | 780 820 | -3,70 | |||
2014-09-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -30 000 | 137 772 | -17,88 | 62,68 | -1 880 400 | 8 635 549 |
2014-09-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -30 000 | 137 772 | -17,88 | 62,68 | -1 880 400 | 8 635 549 |
2014-09-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 30 000 | 283 272 | 11,84 | 0,30 | 9 075 | 85 690 |
2014-09-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -6 500 | 810 820 | -0,80 | ||||
2014-09-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 167 772 | -3,73 | 46,30 | -300 950 | 7 767 844 |
2014-09-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 167 772 | -3,73 | 46,30 | -300 950 | 7 767 844 |
2014-09-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 500 | 259 772 | 2,57 | 0,30 | 1 966 | 78 581 |
2014-08-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 265 | 174 272 | -1,28 | 40,17 | -90 985 | 7 000 506 |
2014-08-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 265 | 253 272 | -0,89 | 40,17 | -90 985 | 10 173 936 |
2014-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -4 235 | 176 537 | -2,34 | 39,17 | -165 885 | 6 914 954 |
2014-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -4 235 | 255 537 | -1,63 | 39,17 | -165 885 | 10 009 384 |
2014-07-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -6 500 | 180 772 | -3,47 | 46,52 | -302 380 | 8 409 513 |
2014-07-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -6 500 | 259 772 | -2,44 | 46,52 | -302 380 | 12 084 593 |
2014-06-20 |
|
4 | FMI |
Foundation Medicine, Inc.
Stock Option (right to buy) |
A - Award | 13 385 | 13 385 | |||||
2014-06-12 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 7 500 | 7 500 | |||||
2014-04-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 54 546 | 817 320 | 7,15 | ||||
2014-03-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -25 000 | 762 774 | -3,17 | ||||
2014-03-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 25 000 | 266 272 | 10,36 | 0,30 | 7 562 | 80 547 | |
2014-03-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -54 000 | 787 774 | -6,42 | ||||
2014-03-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 54 000 | 241 272 | 28,84 | 0,30 | 16 335 | 72 985 | |
2014-03-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 160 000 | 841 774 | 23,47 | ||||
2013-10-02 |
|
4 | FMI |
Foundation Medicine, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -125 000 | 0 | -100,00 | ||||
2013-10-02 |
|
4 | FMI |
Foundation Medicine, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -125 000 | 0 | -100,00 | ||||
2013-10-02 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
C - Conversion | 31 250 | 31 250 | |||||
2013-10-02 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
C - Conversion | 31 250 | 31 250 | |||||
2013-09-24 | 3 | FMI |
Foundation Medicine, Inc.
Common Stock |
31 250 | ||||||||
2013-07-23 | 3 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
187 272 | ||||||||
2013-07-23 | 3 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
187 272 |